- Muhartono
Bagian Patologi Anatomi Fakultas Kedokteran Universitas Lampung, jalan Soemantri Brojonegoro 1 Bandar Lampung

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

KORELASI ANTARA IMUNOEKSPRESI P53 DAN RESPONS KEMOTERAPI NEOADJUVAN REGIMEN FLUORORASIL, ADRIAMISIN, DAN SIKLOFOSFAMID PADA KARSINOMA DUKTUS PAYUDARA INVASIF Muhartono, -; Hanriko, Rizki
Majalah Kedokteran Bandung Vol 44, No 1 (2012)
Publisher : Faculty of Medicine, Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (915.71 KB)

Abstract

Karsinoma duktus payudara invasif (KDPI) stadium IIIB perlu penanganan multimodalitas. Kemoterapi neoadjuvan (KN) diberikan untuk menurunkan ukuran dan stadium tumor agar dapat dilakukan operasi. Regimen KN yang biasanya digunakan yaitu fluororasil, adriamisin, dan siklofosfamid (FAS). Kemoterapi FAS bekerja dengan cara merusak deoxyribonucleic acid dan menginduksi apoptosis sel kanker. Terjadinya kelainan protein atau gen yang berhubungan dengan apoptosis (p53) diduga mempengaruhi respons kemoterapi tersebut. Tujuan penelitian ini untuk mengetahui korelasi imunoekspresi p53 dengan respons kemoterapi neoadjuvan FAS. Penelitian ini merupakan penelitian analitik potong lintang terhadap 40 kasus KDPI yang diberikan KN FAS di Rumah Sakit Dr. Hasan Sadikin Bandung periode Maret 2008?Februari 2009. Respons KN FAS dinilai berdasarkan ukuran massa tumor setelah pemberian FAS. Blok parafin penderita dibuat pulasan hematoksilin-eosin dan imunohistokimia dengan menggunakan mouse monoclonal antibody p53 protein (Novocastra), kemudian ditentukan tingkat imunoekspresi p53. Uji statistik dengan Somers?d dan Gamma untuk menguji korelasi antar variabel. Nilai p<0,05 secara statistik dianggap bermakna. Pada 40 kasus KDPI, 20 berespons dan 20 kasus tidak berespons terhadap KN FAS; 13 kasus terekspresi p53>75%, 14 kasus p53=10?75%, 7 kasus p53<10%, dan 6 kasus tidak terekspresi p53. Terdapat korelasi bermakna antara imunoekspresi p53 dan respons kemoterapi FAS (p=0,000). Simpulan, semakin tinggi ekspresi p53, semakin tidak berespons terhadap KN FAS. Imunoekspresi p53 dapat memprediksi respons KN FAS pada KDPI stadium IIIB. [MKB. 2012;44(1):13?8].Kata kunci: Karsinoma duktus payudara invasif, imunoekspresi, p53 Correlation between p53 Immunoexpression and Fluorouracyl, Adriamycin and Cyclophosphamide Regimen Neoadjuvant Chemotherapy Responses in Invasive Ductal Breast CarcinomaInvasive ductal breast carcinoma (IDBC) stage IIIB need multimodality treatment. Neoadjuvant chemotherapy (NC) is given to reduce the size and stage of tumor so that surgery can be performed. Neoadjuvant chemotherapy regimens generally used was fluorouracil, adriamycin and cyclophosphamide (FAC). FAC chemotherapy works by damaging deoxyribonucleic acid and induce apoptosis of cancer cells. Abnormalities of proteins or genes associated with apoptosis (p53) is believed to affect the chemotherapy response. This study was purpose to determine correlation between immunoexpression of p53 and response of neoadjuvant FAC chemotherapy in invasive ductal breast carcinoma. The study was a cross sectional analytic study of 40 IDBC cases given FAC NC at Dr. Hasan Sadikin Hospital Bandung between March 2008?February 2009. Response of FAC NC judged on the size of tumor mass following administration of FAC. Haematoxylin-eosin and immunohistochemistry stain using a mouse monoclonal antibody to p53 protein (Novocastra) was made from paraffin blocks of patients, then determined the immunoexpression levels of p53. Somers?d and Gamma statistical were used to test the correlation between variables. The p-value <0.05 was considered statistically significant. In 40 IDCB cases, 20 cases were responded and 20 cases did not respond to FAC NC; 13 cases expressed p53>75%, 14 cases p53 10?75%, 7 cases p53<10%, and 6 cases were not expresed p53; There was a significant correlation between immunoexpression of p53 and the response of FAC chemotherapy (p=0.000). In conclusions, the higher expression of p53, the lower response to NC FAC. Immunoexpression of p53 can predict the response of FAC NC on IDBC stage IIIB. [MKB.2012;44(1):13?8].Key words: Immunoexpression, invasive ductal breast carcinoma, p53 DOI: http://dx.doi.org/10.15395/mkb.v44n1.209
SENYAWA BRUSEIN-A DARI BUAH MAKASAR (BRUCEA JAVANICA (L.) MERR.) SEBAGAI ANTIPROLIFERASI TERHADAP SEL KANKER PAYUDARA T47D Subeki, -; Muhartono, -
Majalah Kedokteran Bandung Vol 47, No 1 (2015)
Publisher : Faculty of Medicine, Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (700.059 KB)

Abstract

Pada saat ini,insidensi kanker payudara telah menempati urutan teratas pada wanita penderita kanker di negara berkembang termasuk Indonesia, sehingga pencarian obat yang lebih tepat masih diperlukan. Tujuan penelitian ini untuk menentukan aktivitas antiproliferasi senyawa brusein-A terhadap sel kanker payudara T47D secara in vitro. Brusein-A diisolasi dari buah makasar (Brucea javanica (L.) Merr.) dan struktur senyawa yang diperoleh dielusi dengan spektroskopi data. Aktivitas antikanker diamati sebagai antiproliferasi terhadap sel kanker payudara T47D. Antiproliferasi diuji dengan penambahan sulfo rodamin B pada media kultur sel. Masing-masing sumur mengandung 30.000 sel yang diberikan brusein-A dengan variasi 10 konsentrasi antara lain 0,04 µg/mL, 0,08 µg/mL, 0,16 µg/mL, 0,31 µg/mL, 0,63 µg/mL, 1,25 µg/mL, 2,5 µg/mL, 5 µg/mL, 10 µg/mL, dan 20 µg/mL selama 72 jam. Percobaan diulang dua kali dan selanjutnya persentase viabilitas sel dihitung. Hasil penelitian menunjukkan bahwa nilai IC50 brusein-A terhadap sel T47D memberikan efek antiproliferasi sebesar 0,54 µg/mL dengan cisplatin 0,43 µg/mL sebagai kontrol positif. Simpulan, brusein-A mempunyai aktivitas antiproliferasi terhadap sel kanker payudara T47D. [MKB. 2015;47(1):22?8]Kata kunci:  Antiproliferasi, buah makasar, Brucea  javanica, brusein-A, sel kanker T47DBrucein-A Compound of Makasar Fruit (Brucea javanica (L.) Merr.) as Antiproliferative Agent against T47D Breast Cancer CellsBreast cancer is currenly the number one cancer of all cancers attacking women, especially those who live in developing countries including Indonesia. Therefore, the pursuit of  drugs for breast cancer is still needed. The aim of this study was to determine the anti proliferative activity of brucein-A against breast cancer T47D cells in vitro. Bruceine-A was isolated from ?buah makasar? (Brucea javanica (L.) Merr) and the structure of the isolated compound was elucidated by spectral data. The activities of anticancer were evaluated from the antiproliferative effects on T47D breast cancer cell line . The antiproliferative effects were examined in cultured cells stained with sulforhodamin B. Each well contained 30,000 cells, which was treated with bruceine-A in 10 concentration variations of 0.04 µg/mL, 0.08 µg/mL, 0.16 µg/mL, 0.31 µg/mL, 0.63 µg/mL, 1.25 µg/mL, 2.5 µg/mL, 5 µg/mL, 10 µg/mL, and 20 µg/mL for 72 hours. The experiment was replicated twice and the inhibitory percentage of cells was then calculated. The results showed that the IC50 value of bruceine-A on T47D cells as anantiproliferative effect was0.54 µg/mL with cisplatin 0.43 µg/mL as the positive control. In conclusion, bruceine-A has an antiproliferative activity on T47D breast cancer cell line. [MKB. 2015;47(1):22?8]Key words: Antiproliferative, buah makasar, Brucea javanica, brucein-A, cancer T47D cell DOI: 10.15395/mkb.v47n1.394